CooperCompanies Releases 2021 Environmental, Social and Governance Highlights Report, Signs on to United Nations Global Compact

By Staff
Thursday, May 19, 2022 12:27 AM SAN RAMON, Calif.—CooperCompanies (NYSE: COO) has announced the publication of its 2021 Environmental, Social and Governance (ESG) Highlights Report, sharing the company’s progress on ESG items most important to its businesses and stakeholders, including employees, shareholders, customers and global communities.

DrChrono Receives 2022 MedTech Breakthrough Award for Work on Health Platform That Powered a COVID-19 Vaccination Project

By Staff
Thursday, May 19, 2022 12:18 AM SUNNYVALE, Calif.—DrChrono Inc., a platform for electronic health records and medical practices, has been selected as the winner of the “EHR Innovation” award in the sixth annual MedTech Breakthrough Awards program. DrChrono worked with CORE (Community Organized Relief Effort), an emergency relief non-profit organization co-founded by Sean Penn and Ann Lee, Curogram, a leading HIPAA-compliant patient communications tool and messaging platform, and the state of Georgia to operate mobile and fixed COVID-19 vaccine sites, with a goal to deliver vaccines to underserved patients throughout all 18 health districts in Georgia, according to the company’s recent announcement.

All U.S. Executives Spot Potential Risks in AI

By Staff
Wednesday, May 18, 2022 9:00 AM In the U.S., 56 percent of executives believe AI technology comes with either significant or somewhat significant potential risk. Another 19 percent view the risk as moderate, while 26 percent think the threat is minimal. No executive surveyed believes AI is entirely without risk.

Executives name cybersecurity as the No. 1 AI-related risk to their organization, but they may be missing the very real threat of algorithmic bias. Most U.S. companies use AI for hiring and people management, but 39 percent of executives said no one at their company is responsible for identifying implicit bias in the tech. 

Meanwhile, 38 percent report their corporate board isn’t fully aware of how the company uses AI, likely exacerbating blind spots about the risks involved.

Alcon Celebrates 75th Anniversary and Notes its History of Breakthrough Innovation in Eyecare

By Staff
Tuesday, May 17, 2022 12:24 AM GENEVA—On Monday, Alcon marked the company’s 75th anniversary with its “Brilliant History, Brilliant Future” celebration. On May 16, 1947, Alcon Laboratories Inc. was incorporated and began manufacturing specialty pharmaceutical products in Fort Worth, Texas, the company noted in its announcement.

Kits Reports Slight Sales Decline in First Quarter Total Revenue and Notes Large Growth in Eyeglasses Revenue

By Staff
Friday, May 13, 2022 12:24 AM VANCOUVER, Canada—Kits Eyecare Ltd. (TSX: KITS / OTCQX: KTYCF), a direct-to-consumer glasses manufacturer and digital eyecare provider, reported this week that its revenue in the first quarter dipped roughly 2 percent to $20.1 million.

Final Two Companies Reach a Settlement in Long-Running Contact Lens Price-Fixing Suit

By Staff
Friday, May 13, 2022 12:21 AM JACKSONVILLE, Fla.—Bringing a long-running price-fixing case closer to a conclusion, a federal judge in Florida this week gave preliminary approval to proposals from Alcon Vision LLC and Johnson & Johnson Vision Care that would settle their roles in the matter, according to a May 9 court filing.

Alcon Reports Double-Digit Sales Growth in Vision Care, Surgical in First Quarter

By Staff
Thursday, May 12, 2022 12:24 AM GENEVA—Calling its performance “a strong start to the year,” Alcon (SIX/NYSE:ALC) reported that worldwide sales increased 14 percent on a reported basis to $2.2 billion in its first quarter ended March 31.

Bausch Health Companies Inc. Announces ‘Stable’ First-Quarter 2022 Results

By Staff
Wednesday, May 11, 2022 12:21 AM LAVAL, Quebec—Bausch Health Companies Inc. (NYSE/TSX: BHC) yesterday reported $1.918 billion in total revenue for the first quarter of 2022, as compared to $2.027 billion in the first quarter of 2021, a decrease of $109 million, or 5 percent.

CooperVision Kicks Off 2022 Myopia Management Workshop Series

By Staff
Tuesday, May 10, 2022 12:21 AM SAN RAMON, Calif.—CooperVision, a global leader in myopia management, has kicked off its 2022 Myopia Management Workshop series. The immersive full-day events are designed to accelerate practices’ clinical and business success in the fast-growing sector.

Bausch + Lomb Completes Stock Offering and Becomes Independent Publicly Traded Company, Shares Rise on First Trading Day

By Staff
Monday, May 9, 2022 12:21 AM VAUGHAN, Ontario—At the end of a topsy-turvy week for the stock market, Bausch + Lomb Corp. (NYSE/TSX: BLCO) on Friday launched as an independent, publicly traded company when it began trading under the “BLCO” symbol on the New York Stock Exchange and Toronto Stock Exchange.

CooperVision Seeks Proposals for 2022 Science and Technology Awards

By Staff
Friday, May 6, 2022 12:15 AM SAN RAMON, Calif.—To promote continuous advancement in contact lens research and development, CooperVision is now accepting submissions for its 2022 Science and Technology Awards program.

Johnson & Johnson Vision Named a Winner of Fast Company’s 2022 ‘World Changing Ideas Awards’ for Acuvue Theravision With Ketotifen

By Staff
Thursday, May 5, 2022 12:15 AM JACKSONVILLE, Fla.—Johnson & Johnson Vision, a leader in eye health and part of the Johnson & Johnson MedTech Companies, was recognized as the winner of Fast Company’s 2022 World Changing Ideas Awards in the Wellness category for Acuvue Theravision with Ketotifen (etafilcon A drug-eluting contact lens with ketotifen). Each lens contains 19 mcg ketotifen. Fast Company also selected Acuvue Theravision with Ketotifen for an honorable mention in both the Health and Enduring Impact: 15+ Years in Business categories, according to the company’s announcement.

Johnson & Johnson Vision Appoints Peter Menziuso as Company Group Chairman

By Staff
Wednesday, May 4, 2022 12:33 AM JACKSONVILLE, Fla. and SANTA ANA, Calif.—Johnson & Johnson Vision, a global eye health company and part of Johnson & Johnson MedTech, has named Peter Menziuso as company group chairman, according to an announcement Tuesday. Menziuso now leads the full Johnson & Johnson Vision portfolio, which offers solutions designed to provide healthy sight for life. This includes world-leading brands such as Acuvue contact lenses, Tecnis family of intraocular lenses and TearScience LipiFlow, among other brands and products.

VisionWeb Appoints Nicolas Sinet as CEO and Robert Carrier as CTO

By Staff
Wednesday, May 4, 2022 12:27 AM AUSTIN, Texas—VisionWeb, a leading provider in optometry software technology, has appointed Nicolas Sinet as the company’s CEO.

Inspecs Group Reports Rise in Q1 Revenues

By Staff
Friday, April 29, 2022 12:24 AM BATH, England—Inspecs Group plc (LSE: SPEC), a leading designer, manufacturer and distributor of eyewear (sunglasses, optical frames and lenses) announced this week the Group's trading update for the three months ending March 31, 2022.